Author: weldonpc

New research shows younger adults with non-small cell lung cancer have more genetic changes that may respond to targeted therapies.

Access to clinical trials is hindered by geographic, financial, and logistical barriers, despite promising matches.

Stanford researchers develop a two-headed molecule that flips a lymphoma-driving protein into an agent of cell death in mice.

New research highlights how immunotherapy enables the body’s defenses to fight cancer more effectively.

Probiotic bacteria engineered to target pancreatic tumors may enhance cancer treatments when combined with existing therapies.